Giant Fibroadenomas in Young Women
Abstract
Objectives: In this study, we consider a fibroadenoma with a size >5 cm as a giant fibroadenoma (GFA). This definition is not universally accepted but has been used in several studies. We retrospectively presented fibroadenoma cases that were treated in our clinic, together with a review of the current literature.
Materials and Methods: The GFA cases that were surgically treated in our clinic between January 2016 and December 2019 were retrospectively reviewed. The data were collected from patient files, discharge reports, surgical notes, pathology reports, patient follow-up forms, and digital records. Patients whose data were not fully available were excluded from the study. The patients were analyzed in terms of age, duration of symptom, macroscopically size of the mass and location.
Results: Eight patients were analyzed. The mean age of the patients was 31.5±5.8 (23-41) years. The mean time of diagnosis before the operation was 36.75±14.49 (18-60) months. The lesion was in the left breast for five patients (62.5%) and in the right breast for three patients (37.5%). The mean size of fibroadenomas was 52.5±2 (50-56) mm.
Conclusion: There is not a consensus in the ideal treatment protocol of GFAs. A careful physical examination and radiological examination are sufficient for diagnosis, but a biopsy will be beneficial in the context of a GFA. We think that excision should be done in the treatment of GFAs.
Keywords
Giant Fibroadenoma, Treatment, Biopsy
Ethical Statement
Ethics Committee Approval: Ethics committee approval was received from University of Health Sciences, Elazığ Fethi
Sekin State Hospital (no: 13281952-702.99, date: 01.09.2020). Informed Consent: Before surgery, patients signed an informed consent form for the surgical procedure and subsequent treatment, and the necessary permission was obtained to use their data in our analyses. Peer-review: Externally peer-reviewed.
References
- 1. Greenberg R, Skornick Y, Kaplan O. Management of breast fibroadenomas. JGen Intern Med. 1998;13:640-645.
- 2. Carty NJ, Carter C, Rubin C, et al. Management of fibroadenoma of thebreast. Ann R Coll Surg Engl. 1995;77:127-130.
- 3. Hubbard JL, Cagle K, Davis JW, et al. Criteria for excision of suspected fibroadenomas of the breast. Am J Surg. 2015;209:297-301.
- 4. Hille-Betz U, Klapdor R, Henseler H, et al. Treatment of Giant Fibroadenoma in Young Women: Results after Tumor Excision without Reconstructive Surgery. Geburtshilfe Frauenheilkd. 2015;75:929-934.
- 5. Bayrak İK, Özmen Z, Elmalı M, et al. Giant Juvenile Fibroadenoma: Report Of Two Cases With Ultrasonography And Magnetic Resonance Imaging Findings. J Breast Health. 2008;4:43-45.
- 6. Sosin M, Pulcrano M, Feldman ED, et al. Giant juvenile fibroadenoma: a systematic review with diagnostic and treatment recommendations. Gland Surg. 2015;4:312-321.
- 7. Cosmacini P, Zurrida S, Veronesi P, et al. Phyllodes tumor of the breast: mammographic experience in 99 cases. Eur J Radiol. 1992;15:11-14.
- 8. Buchberger W, Strasser K, Helm K, et al. Phyllodes tumor: findings on mammography, sonography and aspiration cytology in 10 cases. AJR Am J Roentgenol. 1991;157:715-719.
- 9. Erözgen F, Kocakuşak A, Kızılkaya C, et al. Treatment Approaches to Recurrent Breast Phyllodes Tumors. Med Bull Haseki. 2012;50:43-47.
- 10. Karaveli FŞ. Fibroepitelyal Lezyonla. Karaveli FŞ, Kapucuoğlu N, çeviri editörleri. Meme Biyopsilerinin Yorumu. Nobel Tıp Kitabevi, 2014; p. 171- 182.